References
- GauthierSFerrisSOutcome measures for probable vascular dementia and Alzheimer’s disease with cerebrovascular diseaseInt J Clin Pract Suppl20011202939
- Department of HealthLiving Well with Dementia: A National Dementia Strategy2009 Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/168220/dh_094051.pdfAccessed January 4, 2018
- Department of HealthPrime Minister’s Challenge on Dementia2012 Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215101/dh_133176.pdfAccessed January 4, 2018
- Joosten-Weyn BanninghLVernooij-DassenMRikkertMOTeunisseJPMild cognitive impairment: coping with an uncertain labelInt J Geriatr Psychiatry200823214815417578843
- LuY-FYHaaseJEFarranCJPerspectives of persons with mild cognitive impairment: sense of being ableAlzheimers care today2007817586
- McIlvaneJMPopaMARobinsonBHouseweartKHaleyWEPerceptions of Illness, coping, and well-being in persons with mild cognitive impairment and their care partnersAlzheimer Dis Assoc Disord200822328429218580593
- WeinerMWVeitchDPAisenPSAlzheimer’s Disease Neuroimaging InitiativeThe Alzheimer’s disease neuroimaging initiative: a review of papers published since its inceptionAlzheimers Dement201281 supplS1S6822047634
- FrankLLenderkingWRHowardKCantillonMPatient self-report for evaluating mild cognitive impairment and prodromal Alzheimer’s diseaseAlzheimers Res Ther2011363522152342
- Department of HealthGuidance on the Routine Collection of Patient Reported Outcome Measures (PROMs)2009 Available from: http://webarchive.nationalarchives.gov.uk/20130105081711/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_092625.pdfAccessed January 4, 2018
- European Medicines AgencyReflection Paper on the Regulatory Guidance for the Use of Health Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products2005 Available from: https://www.ispor.org/workpaper/emea-hrql-guidance.pdfAccessed January 4, 2018
- U.S. Department of Health and Human Services FDA Center for Drug Evaluation and ResearchU.S. Department of Health and Human Services FDA Center for Biologics Evaluation and ResearchU.S. Department of Health and Human Services FDA Center for Devices and Radiological HealthGuidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth Qual Life Outcomes200647917034633
- DeanKJenkinsonCWilcockGWalkerZThe development and validation of a patient-reported quality of life measure for people with mild cognitive impairmentInt Psychogeriatr201426348749724308688
- PetersenRCSmithGEWaringSCIvnikRJKokmenETangelosEGAging, memory, and mild cognitive impairmentInt Psychogeriatr19979suppl 16569
- CronbachLCoefficient alpha and the internal structure of testsPsychometrika1951163297334
- NunnallyJBernsteinIPsychometric Theory3rd edNew YorkMcGraw Hill1994
- WareJEKosinskiMKellerSDSF-36 Physical and Mental Summary Scores, a User’s ManualBostonThe Health Institute, New England Medical Centre1994
- ShroutPEFleissJLIntraclass correlations: uses in assessing rater reliabilityPsychol Bull197986242042818839484
- PetersenRCRobertsROKnopmanDSPrevalence of mild cognitive impairment is higher in menNeurology2010751088989720820000
- innovation.ox.ac.uk [webpage on the Internet]The Mild Cognitive Impairment Questionnaire (MCQ)Oxford University Innovation2014 Available from: https://innovation.ox.ac.uk/outcome-measures/mild-cognitive-impairment-questionnaire-mcq/Accessed January 4, 2018